The U.S Catheters Market to reach $2.4 billion by 2030; Aging population, growing chronic diseases, technological advancements, rising surgical procedures, home healthcare growth are driving the growth of U.S Catheters Market.

The U.S Catheters Market size is estimated to reach $2.4 billion by 2030, growing at a CAGR of 5.5% during the forecast period 2024-2030, according to a recent report published by IndustryARC, titled, “U.S Catheters Market–By Functionality (Diagnostic Catheters, Therapeutic Catheters, Electrophysiology Catheters), By Age Group (Adults, Pediatrics, Geriatrics), By Material (Polyurethane, Silicone, Latex, Others), By Type (Cardiovascular Catheters, Urology Catheters, Neurovascular Catheters, Specialty Catheters), By Application (Cardiovascular Disorders, Urinary Tract Disorders, Neurovascular Disorders, General Surgery, Others), By Distribution Channel (Offline and Online)- Opportunity Analysis & Industry Forecast, 2024-2030.”

Demand is driven by an aging population as older adults increasingly need catheter related treatments. These devices are also needed because of the prevalence of chronic diseases such as heart disease and diabetes. Wider adoption is encouraged by technological advancements which improve catheter safety and effectiveness. The numbers of surgical procedures are increasing and catheters play a vital role in medical interventions. Home healthcare also offers a convenient and safer alternative to patients who need catheter-based care. These factors combined drive growth in the U.S Catheters Market.

In terms of product type, cardiovascular catheters accounted for the largest share of 35% of the U.S Catheters Market in 2023. The U.S. catheters market by product type is led by cardiovascular catheters as it is the largest segment, as they are used for diagnosing and treating heart related conditions. The National Center for Biotechnology Information says that each year in the U.S., over one million cardiac catheterization procedures are performed, so they are widely used. Diagnostic and therapeutic applications of these procedures, involving left and right heart catheterizations, are used by interventional cardiologists to treat a variety of clinical needs. The safety and efficacy of the procedure has been greatly improved by advances in catheterization equipment, improved operator expertise, and new techniques to reduce the associated risks. Additionally, the rise in the number of cardiovascular diseases and the growing requirement for minimally invasive treatment procedures boosts the dominance of cardiovascular catheters in this market. Modern cardiology practices need their ability to support precise interventions and improve patient outcomes.

The rising number of people suffering from chronic diseases is a major driver for the U.S. catheters market. The National Institute of Health (NIH) states that the population of persons aged 50 and over with at least 1 chronic disease is expected to nearly double, from 71.52 million in 2020 to 142.66 million in 2050. The American Hospital Association (AHA) also notes that 133 million Americans, about half the population, already have at least one chronic illness, including hypertension, arthritis or heart disease, and that number is expected to rise to 170 million by 2030. The demand for catheters is spurred by chronic diseases like heart disease, which affects over 79 million Americans, and the use of catheters for treatment and management of such diseases, which drives the market.

Growing healthcare needs of older adults is a major driver in the U.S. catheters market, as the population ages. The UN Department of Economics and Social Affairs states the global population of people aged 65 and over is projected to rise from 771 million in 2022 to 1.6 billion by 2050 and the number of people aged 80 and over to triple over the same period. The aging of this demographic continues to drive medical device market demand for catheters and other medical devices to treat such age-related health issues as urinary incontinence, cardiovascular diseases, the chronic illnesses. These conditions require catheters to manage and keep the patient comfortable. One of the reasons for the market growth is as the elderly population increases there is also an increased need for advanced and reliable catheter technologies.

• In August 2024, Siemens Healthineers announced FDA clearance for its ACUSON Origin cardiovascular ultrasound system and the AcuNav Lumos 4D ICE catheter. The AI-powered system enhances diagnostics and procedures across cardiovascular care. The AcuNav Lumos catheter delivers advanced imaging, continuing Siemens’ 24-year legacy in supporting over 2 million patients.

• In September 2024, Shockwave Medical, part of Johnson & Johnson MedTech, launched its Shockwave E8 peripheral intravascular lithotripsy (IVL) catheter in the U.S., after FDA clearance. Designed to treat calcified PAD and CLTI, the catheter offers improved reach and lesion treatment capabilities for complex cases, enhancing patient care

• In August 2024, Centerline Biomedical announced FDA 510(k) clearance for its IOPS Viewpoint catheter. The 6-French catheter provides 3D navigation feedback, reducing fluoroscopy dependency and radiation exposure during endovascular procedures. This innovation aims to enhance precision, minimize procedure times, and improve outcomes for patients and healthcare providers.

U.S Catheters Market: Competitive Landscape

Key companies profiled in the U.S Catheters Market are Medtronic, Boston Scientific Corporation, Abbott Laboratories, Teleflex Incorporated, Becton, Dickinson and Company (BD), Edwards Lifesciences, Cook Medical, Cardinal Health, Stryker Corporation, AngioDynamics and others.

Catheters Market– Catheters Market size is estimated to reach 33.12 billion by 2027, growing at a CAGR of 8.1% during the forecast period 2022-2027. The key factors driving market growth include the increasing prevalence of chronic diseases such as cardiovascular and urinary disorders, growing demand for minimally invasive surgeries, advancements in catheter technologies, and the rising aging population.

Cardiac Catheters and Guidewires Market – Cardiac Catheters and Guidewires Market size was estimated at $10.8 billion in 2020, growing at a CAGR of 6.8% during the forecast period 2021-2026; This growth is driven by the rising prevalence of cardiovascular diseases, technological advancements in catheter and guidewire materials, the growing number of catheterization procedures, and the increasing adoption of minimally invasive surgeries.

Central Venous Catheter Market - Central venous catheter market size is estimated to reach US$1.7 billion by 2030, after growing at a CAGR of 5.4% during the forecast period 2024-2030. This growth is attributed to the increasing use of central venous catheters in critical care settings, the rising number of cancer and dialysis patients, growing demand for long-term intravenous treatments, and advancements in catheter materials that improve patient safety.

IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets.  

IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format that assists an intelligent and informed decision-making process.

Mr. Venkat Reddy

IndustryARC

Email: [email protected]

USA: (+1) 518-282-4727

Web: https://www.industryarc.com

Follow us on LinkedIn | Facebook | Twitter